J. Mitchell Jones, J.D., Ph.D.
Dr. Jones counsels clients on patent, trademark and trade secret issues. Dr. Jones has extensive experience in obtaining, litigating and licensing patents. Dr. Jones has a special emphasis in patents in life science disciplines, and has obtained hundreds of patents worldwide for clients in the following areas: fatty acid nutraceuticals, retroviral vectors, cell culture, recombinant proteins, transgenic animals, stem cells, transgenic plants, plant cultivars, plant transformation, bioenergy and biofuels, cold storage of organs, liquid crystals, nanotechnology, high-throughput screening methodologies, artificial skin, cell assays, and biochips.
Dr. Jones has experience in representing US and international companies, from start-ups to Fortune 500 companies, as well as leading United States universities. Dr. Jones actively participates with clients in designing sophisticated intellectual property protection strategies for their assets and for the maximization of their intellectual property resources (IPR), as well as strategies for assuring freedom to operate in complex business environments.
Founding Shareholder, Casimir Jones S.C., 2007 to present
Partner, Medlen & Carroll, LLP, 2001-2007
Associate, Medlen & Carroll, LLP, 1998-2001
Michael, Best & Friedrich, 1997-1998
Vanderbilt University, Juris Doctor, 1997
University of Wisconsin, Ph.D., Endocrinology-Reproductive Physiology, 1994
University of Tennessee, B.S., Agriculture, 1988
Hoffmann-LaRoche, Inc. v. Promega Corporation
1999 U.S. Dist. LEXIS 19059 (N.D. Cal 1999)
323 F.3d 1354, 66 USPQ2d 1385 (Fed. Cir. 2003)
2003 US. App. LEXIS 14802 (Fed. Cir. 2003)
Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals Inc., (W.D. Wis.)
1. “Cell Cycle Mediated Repression of Transcription in Mammalian Embryos,” Ph.D. Thesis, University of Wisconsin (1994).
2. “Expression of the Cell Cycle Control Protein cdc25 in Cleavage Stage Bovine Embryos,” Zygote 3(2):133-139 (1995).